Drugs for Endometrial Hyperplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 58)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Medroxyprogesterone acetate |
Approved, Investigational |
Phase 4 |
|
520-85-4, 71-58-9 |
6279 10631 |
Synonyms:
(6ALPHA)-17-(ACETYLOXY)-6-METHYLPREG-4-ENE-3,20-DIONE
(6α)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17 alpha Hydroxy 6 alpha methylprogesterone
17 alpha-Hydroxy-6 alpha-methylprogesterone
17-ACETOXY-6ALPHA-METHYLPROGESTERONE
17-ACETOXY-6Α-METHYLPROGESTERONE
17a-Hydroxy-6a-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone
17ALPHA-HYDROXY-6ALPHA-METHYLPROGESTERONE ACETATE
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17-Hydroxy-6a-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6a-methylprogesterone
17-Hydroxy-6α-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6α-methylprogesterone
17Α-hydroxy-6α-methylprogesterone
17Α-HYDROXY-6Α-METHYLPROGESTERONE ACETATE
6ALPHA-METHYL-17-ACETOXY PROGESTERONE
6-ALPHA-METHYL-17-ALPHA-ACETOXYPROGESTERONE
6alpha-Methyl-17alpha-hydroxyprogesterone
6ALPHA-METHYL-17ALPHA-HYDROXYPROGESTERONE ACETATE
6-ALPHA-METHYL-17-ALPHA-HYDROXYPROGESTERONE ACETATE
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6ALPHA-METHYL-4-PREGNENE-3,20-DION-17ALPHA-OL ACETATE
6a-Methyl-17a-hydroxyprogesterone
6a-Methyl-4-pregnen-17a-ol-3,20-dione
6Α-METHYL-17-ACETOXY PROGESTERONE
6Α-methyl-17α-hydroxyprogesterone
6Α-METHYL-17Α-HYDROXYPROGESTERONE ACETATE
6Α-methyl-4-pregnen-17α-ol-3,20-dione
6α-Methyl-4-pregnene-3,20-dion-17α-ol acetate
ADGYN MEDRO
AMEN
Aragest
Aragest 5
Asconale
CBP-1011
CLIMANOR
Clinofem
Clinovir
Colirest
CURRETAB
CYCRIN
Depo-Clinovir
Depo-Prodasone
Depo-Progestin
DEPO-PROGEVERA
Depo-Promone
DEPO-PROVERA
DEPO-PROVERA ONCOLOGY
DEPO-SUBQ PROVERA 104
Depot-Medroxyprogesterone acetate
DMPA
FARLUTAL
FARLUTAL 100
FARLUTAL 200
FARLUTAL 250
FARLUTAL 500
Farlutal inyectable
|
Farlutin
Gestapuran
G-Farlutal
Hematrol
Hydroxymethylprogesterone
hydroxymethylprogesterone|MPA
Hysron
Indivina
LUNELLE
Lutopolar
Lutoral
MAP
Med-Pro
Medroprogesterone Acetate
Medrossiprogesterone
Medrossiprogesterone [Dcit]
Medroxiprogesterona
Medroxiprogesterona [INN-Spanish]
MEDROXIPROGESTERONE ACETATE
Medroxiprogesteronum
MEDROXYACETATE PROGESTERONE
Medroxyprogesteron
Medroxyprogesteron acetate
MEDROXYPROGESTERONE
MEDROXYPROGESTERONE 17-ACETATE
MEDROXYPROGESTERONE ACETATE
Medroxyprogesterone strakan brand
Medroxyprogesteronum
Medroxyprogesteronum [INN-Latin]
Meprate
METHYLACETOXYPROGESTERONE
Methylhydroxyprogesterone
METIGESTRONA
MPA
MPA Gyn 5
Nadigest
Nidaxin
Novo-Medrone
NSC-21171
NSC-26386
Oragest
Perlutex
Perlutex Leo
PREMPRO
Prodasone
Progestalfa
Progevera
PROVERA
Proverone
Ralovera
Repromap
Repromix
SAYANA PRESS
Sirprogen
Sodelut G
Strakan brand OF medroxyprogesterone
TV-46046
Veramix
|
|
2 |
|
Contraceptive Agents, Male |
|
Phase 4 |
|
|
|
3 |
|
Estrogens, Conjugated (USP) |
|
Phase 4 |
|
|
|
4 |
|
BIRC5 protein, human |
|
Phase 4 |
|
|
|
5 |
|
Bazedoxifene |
Approved, Investigational |
Phase 3 |
|
198481-32-2 |
154257 |
Synonyms:
BAZEDOXIFENE
Bazedoxifene acetate
BAZEDOXIFENE/CONJUGATED ESTROGENS
Bazedoxifeno
CONBRIZA
|
Conbriza®|TSE-424|Viviant®|WAY-140424
TSE 424
TSE-424
VIVIANT
WAY-140424
|
|
6 |
|
Raloxifene |
Approved, Investigational |
Phase 3 |
|
82640-04-8, 84449-90-1 |
5035 |
Synonyms:
(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone
Eviden
EVIREX
Evista
Evista®|LY-156758|Optruma®|raloxifene hydrochloride
J22.982B
Keoxifene
KEOXIFENE HCL
Keoxifene hydrochloride
LY 139481
LY-139481
LY156758
LY-156758
|
OPTRUMA
OSTIRAL
RAL
Raloxifene
Raloxifène
Raloxifene HCL
Raloxifene hydrochloride
Raloxifeno
Raloxifeno [Spanish]
Raloxifenum
Raloxifenum [Latin]
Raxeto
RAZYLAN
|
|
7 |
|
Metformin |
Approved |
Phase 2, Phase 3 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
8 |
|
Levonorgestrel |
Approved, Investigational |
Phase 2, Phase 3 |
|
797-63-7 |
13109 |
Synonyms:
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one
(+-)-Norgestrel
(8R,9S,10R,13S,14S,17R)-13-ETHYL-17-ETHYNYL-17-HYDROXY- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- TETRADECAHYDROCYCLOPENTA[A] PHENANTHREN-3-ONE
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one
13-Ethyl-17-a-ethynyl-17-b-hydroxy-4-gonen-3-one
13-Ethyl-17-a-ethynylgon-4-en-17-b-ol-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
13-Ethyl-17-α-ethynyl-17-β-hydroxy-4-gonen-3-one
13-Ethyl-17-α-ethynylgon-4-en-17-β-ol-3-one
13-Β-ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one
17-a-Ethinyl-13-b-ethyl-17-b-hydroxy-4-estren-3-one
17a-Ethynyl-13b-ethyl-3-oxo-4-estren-17b-ol
17-a-Ethynyl-13-ethyl-19-nortestosterone
17a-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17a-Ethynyl-18-homo-19-nortestosterone
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nortestosterone
17-Ethynyl-18-methyl-19-nortestosterone
17-Α-ethinyl-13-β-ethyl-17-β-hydroxy-4-estren-3-one
17-Α-ethynyl-13-ethyl-19-nortestosterone
17Α-ethynyl-13β-ethyl-3-oxo-4-estren-17β-ol
17Α-ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17Α-ethynyl-18-homo-19-nortestosterone
18-Methyl-17-a-ethynyl-19-nortestosterone
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methyl-17-α-ethynyl-19-nortestosterone
18-Methylnorethisterone
Alcala brand OF levonorgestrel
ATHENTIA NEXT
Aventis pharma brand OF levonorgestrel
BAY86-5028
Berlex brand OF levonorgestrel
Capronor
Cerazet
D Norgestrel
D(-)-Norgestrel
D-Norgestrel
Duofem
EMERRES
EMERRES UNA
EZINELLE
FALLBACK SOLO
HER STYLE
Hexal brand OF levonorgestrel
HRA brand 1 OF levonorgestrel
HRA brand 2 OF levonorgestrel
|
ISTERANDA
Jadelle
JAYDESS
KYLEENA
L Norgestrel
Levonelle
LEVONELLE ONE STEP
LEVONELLE-2
Levonorgestrel
LÉVONORGESTREL
Lèvonorgestrel
Levonorgestrel alcala brand
Levonorgestrel berlex brand
Levonorgestrel hexal brand
Levonorgestrel paladin brand
Levonorgestrel wyeth brand
Levonorgestrelum
Levonova
LEVOSERT
LILETTA
L-Norgestrel
l-norgestrel|Norplant®
Microlut
Microluton
Microval
Mirena
Norgeston
NORGESTREL (-)-FORM
NorLevo
Norplant
Norplant 2
NORPLANT II
NORPLANT SYSTEM
Norplant2
Norplant-2
OPCICON ONE-STEP
Ovrette
Paladin brand OF levonorgestrel
Plan b
PLAN B ONE-STEP
Postinor
POSTINOR-2
Schering brand 1 OF levonorgestrel
Schering brand 2 OF levonorgestrel
Schering brand 3 OF levonorgestrel
SKYLA
UPOSTELLE
Vikela
Women's capital brand OF levonorgestrel
WY-3707
WY-5104
Wyeth brand OF levonorgestrel
|
|
9 |
|
Dydrogesterone |
Approved, Investigational, Withdrawn |
Phase 2, Phase 3 |
|
152-62-5 |
9051 |
Synonyms:
(9Β,10Α)-PREGNA-4,6-DIENE-3,20-DIONE
10a-Isopregnenone
10alpha-Isopregnenone
10Α-isopregnenone
6 Dehydro 9 beta 10 alpha progesterone
6-Dehydro-9 beta-10 alpha-progesterone
6-Dehydro-retro-progesterone
9Β,10Α-PREGNA-4,6-DIENE-3,20-DIONE
Dehydrogesterone
delta(6)-Retroprogesterone
DELTA(SUP 6)-RETROPROGESTERONE
Didrogesterona
Didrogesterone
Duphaston
Duphaston®
|
DUPHASTON-HRT
DYDROGESTERONA
DYDROGESTERONE
DYDROGESTÉRONE
Dydrogesteronum
GESTATRON
Gynorest
Hydrogesterone
Hydrogestrone
Isopregnenone
NSC-92336
Retro-6-dehydroprogesterone
Solvay brand OF dydrogesterone
Δ(6)-retroprogesterone
|
|
10 |
|
Progesterone |
Approved, Vet_approved |
Phase 3 |
|
57-83-0 |
5994 |
Synonyms:
(1S,2R,10S,11S,14S,15S)-14-ACETYL-2,15-DIMETHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADEC-6-EN-5-ONE
(8S,9S,10R,13S,14S,17S)-17-ACETYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(8S,9S,10R,13S,14S,17S)-17-ETHANOYL-10,13-DIMETHYL-1,2,6,7,8,9,11,12,14,15,16,17-DODECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
(S)-4-PREGNENE-3,20-DIONE
(S)-PREGN-4-EN-3,20-DIONE
(S)-PROGESTERONE
17ALPHA-PROGESTERONE
17A-PROGESTERONE
17Α-PROGESTERONE
3,20-PREGNENE-4
4-PREGNEN-3,20-DIONE
4-PREGNENE-3,20-DIONE
AGOLUTIN
AKROLUTIN
Amen
BETA-PROGESTERONE
BIO-LUTON
CIDR
COLPROSTERONE
CORLUTIN
CORLUTINA
CORLUVITE
CORPORIN
CORPUS LUTEUM HORMONE
CRINONE
CRINONE PROGESTERONE GEL
CURRETAB
CYCLOGEST
CYCLOGESTERIN
Cycrin
D4-PREGNENE-3,20-DIONE
DELALUTIN
DELTA(4)-PREGNENE-3,20-DIONE
DELTA(SUP 4)-PREGNENE-3,20-DIONE
DURAPROGEN
ENDOMETRIN
ESTIMA
FLAVOLUTAN
FOLOGENON
Gelbkoerperhormon
GELBKÖRPERHORMON
GESTEROL
GESTEROL 100
GESTEROL 50
GESTIRON
GESTONE
GESTORMONE
GESTRON
GLANDUCORPIN
GYNLUTIN
GYNOLUTON
GYNOLUTONE
HORMOFLAVEINE
HORMOLUTON
Hydroxyprogesterone caproate
Hydroxyprogesterone caproic acid
LINGUSORBS
LIPO-LUTIN
LUCORTEUM
LUCORTEUM SOL
LUGESTERON
LUTEAL HORMONE
Luteinique
LUTEOCRIN NORMALE
LUTEODYN
LUTEOGAN
LUTEOHORMONE
LUTEOL
LUTEOPUR
LUTEOSAN
LUTEOSTAB
LUTEOVIS
LUTEUM
LUTEX
LUTIDON
LUTIGEST
|
Lutin
LUTOCICLINA
LUTOCUCLIN M
LUTOCYCLIN
LUTOCYCLIN M
LUTOCYLIN
LUTOCYLOL
LUTOFORM
LUTOGYL
LUTOGYNON
LUTREN
LUTROMONE
MEMBRETTES
METHYLPREGNONE
MPA
NALUTRON
NSC-64377
NSC-9704
PERCUTACRINE
PERCUTACRINE LUTEINIQUE
PIAPONON
PRANONE
PREGN-4-EN-3,20-DIONE
PREGN-4-ENE-3,20-DIONE
PREGNENE-3,20-DIONE
PREGNENEDIONE
PRIMOLUT
PROCHIEVE
PROGEFFIK
PROGEKAN
PROGESTA-CARE
PROGESTAN
PROGESTASERT
PROGESTEROL
PROGESTERON
PROGESTERONA
Progesterona [INN-Spanish]
PROGESTERONE
PROGESTÉRONE
Progesterone, (13 alpha,17 alpha)-(+-)-isomer
Progesterone, (17 alpha)-isomer
Progesterone, (9 beta,10 alpha)-isomer
PROGESTERONUM
Progesteronum [INN-Latin]
PROGESTIN
PROGESTOGEL
PROGESTOL
PROGESTON
PROGESTONE
PROGESTOSOL
PROGESTRON
PROGESTRONOL
PROJESTAJECT
PROLETS
PROLIDON
PROLUTIN
PROLUTON
PROLUTONE
PROMETRIUM
Prometrium®|Utrogestan®
PRONTOGEST
PROTORMONE
REGUMATE
SERENITY FOR WOMEN
SYNGESTERONE
SYNGESTRETS
SYNGESTRONE
SYNOVEX S
SYNTOLUTAN
Thiuram E
Thiuranide
U 3672
UTROGEST
UTROGESTAN
VITARRINE
Δ(4)-pregnene-3,20-dione
|
|
11 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 2, Phase 3 |
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Î’)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Î’ oestradiol
17Î’-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Î’-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Î’-estradiol
|
|
12 |
|
Polyestradiol phosphate |
Approved |
Phase 2, Phase 3 |
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
13 |
|
Letrozole |
Approved, Investigational |
Phase 2, Phase 3 |
|
112809-51-5 |
3902 |
Synonyms:
4,4'-(1H-1,2,4-Triazol-1-yl-methylene)-bis(benzonitrile)
CGS-20267
FEM345
Femara
Fémara
|
Femara®
Letrozol
LETROZOLE
Novartis brand OF letrozole
|
|
14 |
|
Ethinylestradiol |
Approved |
Phase 2, Phase 3 |
|
57-63-6 |
5991 |
Synonyms:
(1S,10R,11S,14R,15S)-14-ETHYNYL-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
17 ALPHA-ETHINYLESTRADIOL
17 ALPHA-ETHYNYLESTRADIOL
17 ALPHA-ETHYNYLOESTRADIOL
17α-ethynylestradiol|ethinyl estradiol
17a-Ethinyl estradiol
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol-L7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17Α-ethinyl estradiol
17Α-ETHYNYLESTRADIOL
Alora
Amenoron
Anovlar
Chee-O-gen
Chee-O-genf
Diognat-e
Diogyn e
Diogyn-e
Dyloform
Effik brand OF ethinyl estradiol
ENOVID
ENOVID-E
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Eston-e
Estoral
Estoral {[orion]}
Estorals
Estradiol, ethinyl
Estradiol, ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl estradiol
Ethinyl estradiol hemihydrate
Ethinyl estradiol, (8 alpha)-isomer
Ethinyl estradiol, (8 alpha,17 alpha)-isomer
Ethinyl estradiol, (8 alpha,9 beta,13 alpha,14 beta)-isomer
Ethinyl estradiol, (9 beta,17 alpha)-isomer
Ethinyl oestradiol effik
Ethinylestradiol
Ethinylestradiol jenapharm
ETHINYLESTRADIOLUM
Ethinylestriol
Ethinyloestradiol
|
Ethinyl-oestradiol effik
ETHINYL-OESTRANOL
Ethynyl estradiol
Ethynylestradiol
ETHYNYLOESTRADIOL
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
ETINILESTRADIOL
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, ethinyl estradiol
Inestra
Innofem
Jenapharm brand OF ethinyl estradiol
Jenapharm, ethinylestradiol
Kolpolyn
Linoral
Lynoral
Menolyn
Menostar
Microfollin
Microfollin forte
Neo-estrone
Nogest-S
NORINYL
Novestrol
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon brand OF ethinyl estradiol
Ovex
OVULEN
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn m
Progynon C
Progynon m
Schering brand OF ethinyl estradiol
Schering-plough brand OF ethinyl estradiol
Spanestrin
Thiuram e
Thiuranide
Vagifem
Ylestrol
|
|
15 |
|
Cyproterone acetate |
Approved, Investigational |
Phase 2, Phase 3 |
|
427-51-0 |
9880 |
Synonyms:
ANDROCUR
ANDROCUR 10
Androcur®|Cyprostat®|SH-714
CYPROSTAT
CYPROSTAT®
CYPROTERONE
|
CYPROTERONE 17-O-ACETATE
CYPROTERONE ACETATE
DIANE
NSC-81430
SH-714
|
|
16 |
|
Estrogen Receptor Modulators |
|
Phase 3 |
|
|
|
17 |
|
Selective Estrogen Receptor Modulators |
|
Phase 3 |
|
|
|
18 |
|
Rosuvastatin Calcium |
|
Phase 2, Phase 3 |
|
147098-20-2 |
|
Synonyms:
CRESTOR
EZALLOR
ROSUVASTATIN CALCIUM
ROSUVASTATIN CALCIUM SALT
|
S-4522
ZD-4522
ZD-4522 (CALCIUM SALT)
|
|
19 |
|
Antimetabolites |
|
Phase 2, Phase 3 |
|
|
|
20 |
|
Calcium, Dietary |
|
Phase 2, Phase 3 |
|
|
|
21 |
|
Hypolipidemic Agents |
|
Phase 2, Phase 3 |
|
|
|
22 |
|
Anticholesteremic Agents |
|
Phase 2, Phase 3 |
|
|
|
23 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
24 |
|
Lipid Regulating Agents |
|
Phase 2, Phase 3 |
|
|
|
25 |
|
Progestins |
|
Phase 3 |
|
|
|
26 |
|
Estradiol 3-benzoate |
|
Phase 2, Phase 3 |
|
|
|
27 |
|
Estradiol 17 beta-cypionate |
|
Phase 2, Phase 3 |
|
|
|
28 |
|
Cyproterone |
|
Phase 2, Phase 3 |
|
2098-66-0 |
5284537 |
Synonyms:
6-Chlor-delta(6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron
6-Chlor-delta(6)-1,2-a-methylen-17-a-hydroxyprogesteron
6-Chlor-δ(6)-1,2-a-methylen-17-a-hydroxyprogesteron
6-Chlor-δ(6)-1,2-α-methylen-17-α-hydroxyprogesteron
Apo-cyproterone
Ciproterona
Ciproterona servycal
|
Ciproterone
CYPROTERONE
Cyproterone acetate
Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-isomer
Cyproteronum
Novo-cyproterone
|
|
29 |
|
Androgens |
|
Phase 2, Phase 3 |
|
|
|
30 |
|
Androgen Antagonists |
|
Phase 2, Phase 3 |
|
|
|
31 |
|
Cyproterone acetate, ethinyl estradiol drug combination |
|
Phase 2, Phase 3 |
|
|
|
32 |
|
Calcium |
Nutraceutical |
Phase 2, Phase 3 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
33 |
|
Norethisterone |
Approved |
Phase 2 |
|
68-22-4 |
199472 6230 |
Synonyms:
(-)-Gallocatechin gallic acid
(-)-Gallocatechin-3-O-gallate
(-)-Gallocatechin-3-O-gallic acid
(-)-Gallocatechol gallate
(-)-Gallocatechol gallic acid
(17a)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17Α)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoic acid)
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoic acid
17a-Ethinyl-19-nortestosterone
17a-Ethinylestra-4-en-17b-ol-3-one
17a-Ethynyl-17b-hydroxy-19-norandrost-4-en-3-one
17a-Ethynyl-17-hydroxy-4-estren-3-one
17-a-Ethynyl-17-hydroxy-4-estren-3-one
17a-Ethynyl-19-nor-4-androsten-17b-ol-3-one
17a-Ethynyl-19-norandrost-4-en-17b-ol-3-one
17-a-Ethynyl-19-norandrost-4-en-17-b-ol-3-one
17a-Ethynyl-19-nortestosterone
17-a-Ethynyl-19-nortestosterone
17a-Ethynyl-4-estren-17-ol-3-one
17-a-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-ethinyl-19-nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17-hydroxy-estr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17-alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-Pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-Ethinyl-19-nor-testosterone
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (acd/name 4.0)
17-Ethynyl-19-nortestosterone
17-Hydroxy-(17alpha)-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one
17Α-ethinyl-19-nortestosterone
17Α-ethinylestra-4-en-17β-ol-3-one
17Α-ethynyl-17-hydroxy-4-estren-3-one
17-Α-ethynyl-17-hydroxy-4-estren-3-one
17Α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one
17Α-ethynyl-19-nor-4-androsten-17β-ol-3-one
17Α-ethynyl-19-norandrost-4-en-17β-ol-3-one
17-Α-ethynyl-19-norandrost-4-en-17-β-ol-3-one
17Α-ethynyl-19-nortestosterone
17-Α-ethynyl-19-nortestosterone
17Α-ethynyl-4-estren-17-ol-3-one
17-Α-ethynyl-4-estren-17-ol-3-one
17Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
17-Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
19-Nor-17a-ethynyl-17b-hydroxy-4-androsten-3-one
19-Nor-17-a-ethynyl-17-b-hydroxy-4-androsten-3-one
19-Nor-17a-ethynylandrosten-17b-ol-3-one
19-Nor-17-a-ethynylandrosten-17-b-ol-3-one
19-Nor-17a-ethynyltestosterone
19-Nor-17-a-ethynyltestosterone
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
|
19-Nor-17alpha-ethynyltestosterone
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyltestosterone
19-Nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one
19-Nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one
19-Nor-17α-ethynylandrosten-17β-ol-3-one
19-Nor-17-α-ethynylandrosten-17-β-ol-3-one
19-Nor-17α-ethynyltestosterone
19-Nor-17-α-ethynyltestosterone
19-Nor-ethindrone
19-Norethinyltestosterone
19-Norethisterone
4-Estren-17a-ethynyl-17b-ol-3-one
4-Estren-17alpha-ethynyl-17beta-ol-3-one
4-Estren-17α-ethynyl-17β-ol-3-one
ACTIVELLA
Anhydrohydroxynorprogesterone
Anovule
AYGESTIN
Camila
COMBIPATCH
Conceplan
Conludaf
Conludag
ENT
ent-Gallocatechin 3-gallic acid
ERRIN
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylnortestosterone
FEMHRT
Gallocatechin gallate
Gallocatechin-3-gallate
Gestest
HEATHER
INCASSIA
JENCYCLA
Menzol
Micronett
Micronor
MICRONOR HRT
Micronor®|norethindrone|Noriday®
Micronovum
Mini-pe
Mini-pill
Minovlar
Monogest
NEA713
NET
Nor QD
Noralutin
Norcolut
Norcolute
Noresthisterone
NORETHIDRONE
Norethindrone
Norethindrone, (1 beta)-isomer
Norethisteron
Norethisterone
Noréthistérone
Norethisteronum
Norethyndron
Norethynodrone
Noretisterona
Norfor
Norgestin
Noriday
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Nor-q.d.
NorQD
Nor-QD
NSC-9564
Primolut N
Primolut-N
Proluteasi
SC-4640
Utovlan
Utovlar
|
|
34 |
|
Everolimus |
Approved |
Phase 2 |
|
159351-69-6 |
70789204 6442177 |
Synonyms:
001, RAD
40-O-(2-Hydroxyethyl)-rapamycin
42-O-(2-HYDROXYETHYL)RAPAMYCIN
Afinitor
AFINITOR DISPERZ
Afinitor®|Certican®|RAD-001|RAD001|rapamycin, 42-O-(2-hydroxyethyl)-|Zortress®
Certican
EVEROLIMUS
évérolimus
RAD 001
|
RAD 666
RAD, SDZ
RAD001
RAD-001
RAD-666
SDZ RAD
SDZ-RAD
VOTUBIA
ZORTRESS
|
|
35 |
|
Sirolimus |
Approved, Investigational |
Phase 2 |
|
53123-88-9 |
5284616 6436030 |
Synonyms:
(-)-Rapamycin
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Antibiotic ay 22989
AY-22989
AY-22989|Fyarro® (sirolimus albumin-bound particles)|Rapamune®|rapamycin|WY-090217
L04AA10
NSC-226080
Perceiva
RAPA
Rapammune
|
Rapamune
Rapamycin
Rapamysin
RPM
Sirolimus
Sirolimús
Sirolimusum
SM-88 COMPONENT SIROLIMUS
WY-090217
|
|
36 |
|
Exemestane |
Approved, Investigational |
Phase 2 |
|
107868-30-4 |
60198 |
Synonyms:
6-Methyleneandrosta-1,4-diene-3,17-dione
Aromasil
Aromasin
Aromasin®|FCE-24304
Aromasine
Examestane
Exemestance
|
EXEMESTANE
Exemestano
Exemestano [INN-Spanish]
Exemestanum
Exemestanum [INN-Latin]
FCE-24304
PNU-155971
|
|
37 |
|
Genistein |
Investigational |
Phase 2 |
|
446-72-0 |
5280961 |
Synonyms:
4',5, 7-Trihydroxyisoflavone
4,5,7-Trihydroxy iso-flavone
4',5,7-Trihydroxyisoflavone
4',5,7-Trihydroxy-isoflavone
5,7,4'-Trihydroxyisoflavone
5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
FW-635I-2
Genestein
GENISTEIN
|
Genistein 85% HPLC
Genisteol
Genisterin
NPI-031L
NSC-36586
Prunetol
SIPI-807-1
Sophoricol
|
|
38 |
|
Norethindrone Acetate |
|
Phase 2 |
|
|
541197 |
Synonyms:
14-Ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl acetic acid
Aygestin
NORETHIDRONE ACETATE
NORETHINDRONE ACETATE
Norethindrone acetate, (17alpha)-(+-)-isomer
Norethindrone acetate, (17alpha)-isomer
|
Norethindrone acetic acid
Norethisterone acetate
Norlutate
NSC-22844
SH-420
|
|
39 |
|
Soy Bean |
|
Phase 2 |
|
|
|
40 |
|
Gonadotropins, Pituitary |
|
Phase 2 |
|
|
|
41 |
|
Immunosuppressive Agents |
|
Phase 2 |
|
|
|
42 |
|
Immunologic Factors |
|
Phase 2 |
|
|
|
43 |
|
Hormones |
|
Phase 2 |
|
|
|
44 |
|
Hormone Antagonists |
|
Phase 2 |
|
|
|
45 |
|
Estrogens |
|
Phase 2 |
|
|
|
46 |
|
Estrogen Receptor Antagonists |
|
Phase 2 |
|
|
|
47 |
|
Estrogen Antagonists |
|
Phase 2 |
|
|
|
48 |
|
Aromatase Inhibitors |
|
Phase 2 |
|
|
|
49 |
|
Formaldehyde |
Approved, Vet_approved |
|
|
50-00-0 |
712 |
Synonyms:
Aldeide formica
Fannoform
Formaldehído
Formaldehyd
Formaldehyde
Formaldehyde solution
FORMALIN
Formalina
Formaline
Formalith
Formic aldehyde
|
Formol
Hyperband
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
|
|
50 |
|
Tamoxifen |
Approved |
|
|
10540-29-1, 54965-24-1 |
2733526 |
Synonyms:
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
1-Para-b-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-Para-β-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-b-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-Î’-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
Apo-tamox
Citofen
Citrate, tamoxifen
Crisafeno
Diemon
EMBLON
FENTAMOX 10
FENTAMOX 20
Gen-tamoxifen
I.C.I.46474 CITRATE
ICI-46474
ICI-46474|Nolvadex®|Soltamox®
ICI-47699
Istubol
KENTADEX
KESSAR
KESSAR 10
KESSAR 20
Noltam
Nolvadex
NOLVADEX D
NOLVADEX FTE
Nolvadex-D
Nourytam
|
Novaldex
Novo-Tamoxifen
OESTRIFEN-10
OESTRIFEN-20
OESTRIFEN-40
Oncomox
PMS-Tamoxifen
Retaxim
Savient brand OF tamoxifen citrate
Soltamox
Tamizam
Tamofen
Tamone
Tamoplex
Tamoxasta
Tamoxen
TAMOXIFEN
Tamoxifen citrate
Tamoxifene
TAMOXIFÈNE
Tamoxifene [INN-French]
Tamoxifeno
Tamoxifeno [INN-Spanish]
Tamoxifenum
Tamoxifenum [INN-Latin]
Tomaxithen
trans-Tamoxifen
Valodex
ZD6157
Zemide
Zitazonium
ZYNOPLEX
|
|
Interventional clinical trials:
(show top 50)
(show all 67)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Multicenter Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia |
Completed |
NCT01074892 |
Phase 4 |
Provera (medroxyprogesterone/progestin);Provera (medroxyprogesterone) |
2 |
The Effect of Metformin and Medroxyprogesterone Acetate on Apoptotic Signaling Pathways in Wistar-Albino Rats With Induced Endometrial Hyperplasia |
Completed |
NCT02872818 |
Phase 4 |
17β estradiol hemihydrate;Metformin;medroxyprogesterone acetate |
3 |
Randomized, Blinded Trial Comparing Vaginal Estrogens on Pelvic Organ Prolapse Patients |
Completed |
NCT03032848 |
Phase 4 |
Conjugated Estrogen;Promestriene;Estriol;Vaginal Moisturizer - Cream |
4 |
A Double-Blind, Randomized, Placebo And Active- Controlled Efficacy And Safety Study Of The Effects Of Bazedoxifene/Conjugated Estrogens Combinations On Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women |
Completed |
NCT00808132 |
Phase 3 |
bazedoxifene 20 mg/ conjugated estrogens 0.45 mg;bazedoxifene 20 mg/ conjugated estrogens 0.625 mg;bazedoxifene 20 mg;conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mg;Placebo |
5 |
A Double-Blind, Randomized, Placebo- And Active-Controlled Efficacy And Safety Study Of Bazedoxifene/Conjugated Estrogens Combinations For Prevention Of Endometrial Hyperplasia And Prevention Of Osteoporosis In Postmenopausal Women |
Completed |
NCT00242710 |
Phase 3 |
Bazedoxifene/Conjugated Estrogen;CE 0.45 mg/MPA 1.5mg |
6 |
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia |
Completed |
NCT04491682 |
Phase 2, Phase 3 |
Megestrol Acetate;Rosuvastatin |
7 |
A Double-Blind, Randomized, Placebo- and Active-Controlled Safety and Efficacy Study of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women |
Completed |
NCT00675688 |
Phase 3 |
Bazedoxifene/Conjugate Estrogens (CE);Raloxifene;Placebo |
8 |
Operational Hysteroscopy Versus Traditional Surgery: Costs and Health Benefits |
Completed |
NCT00490087 |
Phase 3 |
|
9 |
Megestrol Acetate Plus LNG-IUS to Megestrol Acetate or LNG-IUS in Young Women With Endometrial Atypical Hyperplasia |
Completed |
NCT03241888 |
Phase 2, Phase 3 |
Megestrol Acetate |
10 |
The Efficacy of Levonorgestrel Intrauterine System Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia. A Randomized Controlled Trial. |
Recruiting |
NCT04385667 |
Phase 2, Phase 3 |
Oral Megesterol 160 mg daily |
11 |
Medroxyprogesterone Acetate (MPA) Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia |
Recruiting |
NCT03675139 |
Phase 2, Phase 3 |
Medroxyprogesterone Acetate;Dydrogesterone 10 MG |
12 |
MicroRNAs as Biomarkers of Predicting Future Endometrial Malignancy and Longitudinal Follow-up With Randomized Intervention in Women With Endometrial Hyperplasia Without Atypia |
Recruiting |
NCT05292573 |
Phase 3 |
Metformin |
13 |
Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia: A Non-Inferiority Study |
Recruiting |
NCT04897217 |
Phase 3 |
Megestrol Acetate;Levonorgestrel Drug Implant |
14 |
Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma |
Recruiting |
NCT03463252 |
Phase 2, Phase 3 |
Progesterone;GnRH agonist |
15 |
Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical Study |
Recruiting |
NCT05316493 |
Phase 2, Phase 3 |
Megestrol Acetate 160 MG Oral Tablet;Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg |
16 |
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole vs Ethinylestradiol Cyproterone Plus Metformin in Progestin-insensitive Early-stage Endometrial Cancer and Atypical Hyperplasia Patients With Conservative Treatment |
Recruiting |
NCT05316935 |
Phase 2, Phase 3 |
GnRHa;Letrozole 2.5mg;Diane-35;MET |
17 |
A Randomized Controlled Pilot Study of Polyethylene Glycol Loxenatide Plus LNG-IUS in Women With Endometrial Atypical Hyperplasia |
Recruiting |
NCT05172999 |
Phase 2, Phase 3 |
Polyethylene Glycol Loxenatide |
18 |
Comparing Metformin Plus Megestrol Acetate With Megestrol Acetate Alone as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia |
Terminated |
NCT04607252 |
Phase 2, Phase 3 |
Metformin plus Megestrol acetate;Megestrol Acetate |
19 |
Megestrol Acetate Versus Liraglutide Plus Megestrol Acetate in Obese Women With Endometrial Atypical Hyperplasia: A Randomized Controlled Pilot Clinical Study |
Withdrawn |
NCT04683237 |
Phase 2, Phase 3 |
Liraglutide Injection;Megestrol Acetate 160 MG |
20 |
Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System:Single Arm, Prospective Multicenter Study: Korean Gynecologic Oncology Group Study (KGOG2006) |
Unknown status |
NCT01234818 |
Phase 2 |
|
21 |
A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients With Early Stage Cancer of the Endometrium |
Unknown status |
NCT01686126 |
Phase 2 |
Levonorgestrel;Metformin |
22 |
Efficacy & Tolerability of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen Replacement Therapy - Phase II Comparative Study |
Unknown status |
NCT00919919 |
Phase 2 |
progesterone;activella |
23 |
Surgicel® Versus Endometrial Ablation in the Management of Perimenpausal Heavy Menstrual Bleeding (HMB): Randomised Controlled Trial |
Unknown status |
NCT03176992 |
Phase 2 |
SURGICEL® |
24 |
The Effect of Neoadjuvant Depot Medroxyprogesterone Acetate on Glandular Cellularity in Women With Complex Atypical Hyperplasia or Grade 1-2 Endometrial Adenocarcinoma Awaiting Hysterectomy |
Unknown status |
NCT02335203 |
Phase 2 |
Depot medroxyprogesterone acetate |
25 |
Prospective Trial of Conservative Management of Atypical Endometrial Hyperplasia and Well to Moderately Differentiated Endometrial Carcinoma Using Megestrol Acetate |
Completed |
NCT00483327 |
Phase 2 |
Megestrol Acetate |
26 |
Effect of Genistein on Endometrial Hyperplasia |
Completed |
NCT00453960 |
Phase 2 |
Norethisterone Acetate |
27 |
Soy Estrogen Alternative Study (SEA) |
Completed |
NCT00000612 |
Phase 2 |
estrogens, conjugated |
28 |
A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore |
Recruiting |
NCT05492487 |
Phase 2 |
Mirena;Megace |
29 |
Open-Label Randomized Phase II Trial of Megestrol Acetate With or Without Pterostilbene in Patients With Endometrial Cancer Scheduled for Hysterectomy |
Recruiting |
NCT03671811 |
Phase 2 |
Megestrol Acetate |
30 |
Phase II Study of the Levonorgestrel Intrauterine Device Alone or in Combination With the mTORC1 Inhibitor, Everolimus, for the Treatment of Complex Atypical Hyperplasia and Stage Ia Grade 1 Endometrial Cancer |
Recruiting |
NCT02397083 |
Phase 2 |
Everolimus |
31 |
A Phase II Study of the Levonorgestrel Intrauterine Device (Mirena) to Treat Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Carcinoma |
Active, not recruiting |
NCT00788671 |
Phase 2 |
|
32 |
Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer |
Active, not recruiting |
NCT03300557 |
Phase 2 |
Exemestane |
33 |
A Randomized Phase II Evaluation of Continuous Progestin Therapy vs. Sequential Progestin Therapy in the Treatment of Endometrial Intraepithelial Neoplasia (EIN) From a Referred Cohort of Atypical Endometrial Hyperplasia (AEH) or EIN Patients That Desire Uterine Preservation |
Terminated |
NCT00503581 |
Phase 2 |
Megestrol Acetate |
34 |
A Two-Part Study of the Treatment of Atypical Endometrial Hyperplasia: Part A: A Prospective Study of Immediate Hysterectomy; Part B: A Randomized Phase II Study of Medroxyprogesterone Acetate Versus Depoprovera |
Terminated |
NCT00003179 |
Phase 2 |
medroxyprogesterone |
35 |
Levonorgestrel Containing Intrauterine Device in the Treatment of Endometrial Hyperplasia Without Atypia |
Withdrawn |
NCT00123175 |
Phase 1, Phase 2 |
|
36 |
A Phase II Head-to-Head Comparison of Fertility-Sparing Approaches to Treat Complex Atypical Hyperplasia of the Edometrium: Megestrol Versus Levonorgestrel-Releasing Intrauterine System (LNG-IUS) |
Withdrawn |
NCT01943058 |
Phase 2 |
megestrol acetate |
37 |
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC) |
Active, not recruiting |
NCT00892866 |
Phase 1 |
|
38 |
Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study |
Unknown status |
NCT02412072 |
|
|
39 |
Concurrent Endometrial Cancer With Endometrial Hyperplasia or Endometrial Intraepithelial Neoplasia - Focus on Risk Factors Analysis |
Unknown status |
NCT01273636 |
|
|
40 |
The Relation Between Serum Irisin Hormone Level and Endometrial Hyperplasia |
Unknown status |
NCT02903797 |
|
|
41 |
THE EFFECTIVENESS OF MONOPOLAR HOOC VERSUS PLASMAKINETIC BİPOLAR SPATULA USAGE DURING COLPOTOMY PROCESS IN PATIENTS UNDERGOİNG TOTAL LAPAROSCOPIC HYSTERECTOMY |
Unknown status |
NCT04191603 |
|
|
42 |
Role of Senescence in the Development of Endometrial Cancer |
Unknown status |
NCT03338985 |
|
|
43 |
Long-term Observation of Symptomatic Women With Uterine Fibroids Who Have Been Treated With Ulipristal Acetate: Findings on Symptomatology, Morphological Structure, Endometrial Patterns |
Unknown status |
NCT03972917 |
|
|
44 |
Metformin for the Treatment of Endometrial Hyperplasia |
Completed |
NCT01685762 |
Early Phase 1 |
Metformin |
45 |
Women With Asymptomatic Endometrial Hyperplasia |
Completed |
NCT02100137 |
|
|
46 |
Pilot-study of OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer |
Completed |
NCT01961102 |
|
|
47 |
Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination: a Prospective Cohort Study |
Completed |
NCT03917147 |
|
|
48 |
Preliminary Study of Endometrial Hyperplasia: Groundwork for a Study to Define an Optimal Classification of Endometrial Carcinoma Precursors |
Completed |
NCT00339651 |
|
|
49 |
Vaginal Micronized Progesterone or Levonorgestrel-releasing Intrauterine System (LNG-IUS) for Treatment of Non-atypical Endometrial Hyperplasia: A Prospective Randomized Trial |
Completed |
NCT03992937 |
|
Vaginal Micronized Progesterone |
50 |
Office Hysteroscopy in the Infertility Work-out: the Role of Endometrial Hyperplasia in Southern Italian Women |
Completed |
NCT03965585 |
|
|
|